This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Scandion Oncology Dirección

Dirección controles de criterios 0/4

Información clave

Bo Hansen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	1.8yrs
Participación del CEO	0.1%
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	1.2yrs

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates

No hay actualizaciones

CEO

Bo Hansen

1.8yrs

Permanencia

Dr. Bo Rode Hansen, Msc, Ph D, serves as Vice President of Alliance Management & Partnered Drug Discovery at Roche Innovation Center Copenhagen A/S. Dr. Hansen serves as Director at Scandion Oncology A/S s...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Nils Brünner	Co-Founder & Scientific Advisor	no data	sin datos	sin datos
Bo Hansen	President	1.8yrs	sin datos	0.10% DKK 250.4k
Johnny Stilou	Chief Financial Officer	less than a year	sin datos	0.025% DKK 59.0k
Maj Hedtjarn	COO and Head of R&D Operations	1.3yrs	sin datos	0.059% DKK 141.6k
Morten Nissen	General Counsel	no data	sin datos	sin datos
Mads Kronborg	Head of External Communication	less than a year	sin datos	sin datos
Annie Rasmussen	Chief Clinical Officer & Employee Representative Director	less than a year	sin datos	0.049% DKK 118.0k
Alfredo Zurlo	Chief Medical Officer	less than a year	sin datos	sin datos

0.7yrs

Permanencia media

Equipo directivo experimentado: SCOL BTA's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Nils Brünner	Co-Founder & Scientific Advisor	1.3yrs	sin datos	sin datos
Bo Hansen	President	2.2yrs	sin datos	0.10% DKK 250.4k
Annie Rasmussen	Chief Clinical Officer & Employee Representative Director	2.5yrs	sin datos	0.049% DKK 118.0k
Jorgen Vilhelm Bardenfleth	Independent Vice-Chairman of the Board	4.5yrs	sin datos	1.05% DKK 2.5m
Palle Christophersen	Member of Scientific Advisory Board	no data	sin datos	sin datos
Richard Schilsky	Member of Clinical Advisory Board	1.3yrs	sin datos	sin datos
Eric Cutsem	Member of Clinical Advisory Board	less than a year	sin datos	sin datos
Josep Tabernero	Member of Clinical Advisory Board	less than a year	sin datos	sin datos
Susan Bates	Member of Scientific Advisory Board	no data	sin datos	sin datos
Keld Jorgensen	Independent Director	less than a year	sin datos	sin datos
Thomas T. Seufferlein	Member of Clinical Advisory Board	less than a year	sin datos	sin datos
Martin Moller	Independent Chairman of the Board	1.2yrs	sin datos	0.012% DKK 27.7k

1.2yrs

Permanencia media

64.5yo

Promedio de edad

Junta con experiencia: SCOL BTA's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.